Alternative Prescription Therapies Depending on your medical history, options may include: Metformin (especially beneficial for insulin resistance) Bupropion-naltrexone Phentermine Topiramate-based regimens Research shows several non-GLP-1 therapies offer meaningful weight-loss support when used with structured programs (Apovian et al., 2022)
A consultation can determine whether its appropriate
The problem is this: patients have been following their advice, and as a result, they are sicker than they have ever been: Excess weight now accounts for one in three deaths among middle-aged people in the US every year A billion people around the world suffer from diabetes and obesity 50 million people in the US (1 in 6 Americans) suffer from autoimmune diseases like Hashimotos thyroiditis, multiple sclerosis, Crohns disease, and rheumatoid arthritis If you have a thyroid condition like hypothyroidism or Hashimotos, this problem is even worse for you
Lancet 392:615616 Larsen AF, Gydesen S, Sonne N, Karsdal MA, Henriksen K (2021) The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile
If you were prescribed Zepbound without full disclosure of potential long-term risks or were encouraged to use it for purely aesthetic weight loss without medical necessity, your provider and the manufacturer could both face legal exposure